Akebia Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Akebia Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Akebia Therapeutics Inc.
Rating: 1.77275
Author: Trendlyne DVM scores

about

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...

2.99 0.06 (2.05%)

26.72% Fall from 52W High

2.4M

XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.0 / 100

Technically Neutral

58.9 / 100

1Yr Price target upside is 147%

5 analysts

Akebia Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Akebia Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...

26.72% Fall from 52W High

SWOT Analysis

Akebia Therapeutics Inc Live Price Chart